Editing User:Jukeboksi/Wiki.study/Natural therapeutics

Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.

The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.

Latest revision Your text
Line 55: Line 55:
* [https://www.nature.com/articles/npjamd201612 ''''''Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids'''''' at nature.com], a '''2016''' open access research article by researchers from the [[w:Salk Institute]] and [[w:University of California, San Diego]] published in '''npj Aging and Mechanisms of Disease''' finds THC reduces beta amyloid proteins in human neurons.
* [https://www.nature.com/articles/npjamd201612 ''''''Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids'''''' at nature.com], a '''2016''' open access research article by researchers from the [[w:Salk Institute]] and [[w:University of California, San Diego]] published in '''npj Aging and Mechanisms of Disease''' finds THC reduces beta amyloid proteins in human neurons.
** [https://www.salk.edu/news-release/cannabinoids-remove-plaque-forming-alzheimers-proteins-from-brain-cells/ ''''''Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells'''''' at salk.edu], 2016 preliminary reporting on the Salk Institute study.
** [https://www.salk.edu/news-release/cannabinoids-remove-plaque-forming-alzheimers-proteins-from-brain-cells/ ''''''Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells'''''' at salk.edu], 2016 preliminary reporting on the Salk Institute study.
* [https://pubmed.ncbi.nlm.nih.gov/26757043/ ''''''Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study'''''' at pubmed.ncbi.nlm.nih.gov]<ref group="1st seen in">http://www.cannabis-med.org/english/studies.htm</ref>, a '''2016''' study published in the [[w:Journal of Alzheimer's Disease]]


* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562334/ ''''''A Molecular Link Between the Active Component of Marijuana and Alzheimer's Disease Pathology'''''' at ncbi.nlm.nih.gov], a '''2008''' study published in [[w:Molecular Pharmacology]] - ''Compared to currently approved drugs prescribed for the treatment of Alzheimer's disease, THC is a considerably superior inhibitor of Aβ aggregation, and this study provides '''a previously unrecognized molecular mechanism''' through which cannabinoid molecules may directly impact the progression of this debilitating disease.'' (excerpt from the abstract)
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562334/ ''''''A Molecular Link Between the Active Component of Marijuana and Alzheimer's Disease Pathology'''''' at ncbi.nlm.nih.gov], a '''2008''' study published in [[w:Molecular Pharmacology]] - ''Compared to currently approved drugs prescribed for the treatment of Alzheimer's disease, THC is a considerably superior inhibitor of Aβ aggregation, and this study provides '''a previously unrecognized molecular mechanism''' through which cannabinoid molecules may directly impact the progression of this debilitating disease.'' (excerpt from the abstract)
Please note that all contributions to Consumerium development wiki are considered to be released under the GNU Free Documentation License 1.3 or later (see Consumerium:Copyrights for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource. Do not submit copyrighted work without permission!

To protect the wiki against automated edit spam, we kindly ask you to solve the following CAPTCHA:

Cancel Editing help (opens in new window)